{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:52:19Z","timestamp":1790866339339,"version":"4.1.0"},"reference-count":22,"publisher":"BMJ","issue":"7282","license":[{"start":{"date-parts":[[2001,2,10]],"date-time":"2001-02-10T00:00:00Z","timestamp":981763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"accepted":{"date-parts":[[2000,11,9]]},"published-print":{"date-parts":[[2001,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To assess the effectiveness and safety of antiplatelet drugs for prevention of pre-eclampsia and its consequences.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design:<\/jats:bold>\n                    Systematic review.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Data sources:<\/jats:bold>\n                    Register of trials maintained by Cochrane Pregnancy and Childbirth Group, Cochrane Controlled Trials Register, and Embase.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Included studies:<\/jats:bold>\n                    Randomised trials involving women at risk of pre-eclampsia, and its complications, allocated to antiplatelet drug(s) versus placebo or no antiplatelet drug.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Main outcomes measures:<\/jats:bold>\n                    Pre-eclampsia, preterm birth, fetal or neonatal death, and small for gestational age baby. Studies were assessed for quality of concealment of allocation and losses to follow up.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    39 trials (30 563 women) were included, and 45 trials (&gt;3000 women) excluded. Use of antiplatelet drugs was associated with a 15% reduction in the risk of pre-eclampsia (32 trials, 29 331 women; relative risk 0.85, 95% confidence interval 0.78 to 0.92; number needed to treat 100, 59 to 167). There was also an 8% reduction in the risk of preterm birth (23 trials, 28 268 women; 0.92, 0.88 to 0.97; 72, 44 to 200), and a 14% reduction in the risk of fetal or neonatal death (30 trials, 30 093 women; 0.86, 0.75 to 0.98; 250, 125 to &gt;10 000) for women allocated antiplatelet drugs. Small for gestational age babies were reported in 25 trials (20 349 women), with no overall difference between the groups (relative risk 0.92, 0.84 to 1.01). There were no significant differences in other measures of outcome.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Antiplatelet drugs, largely low dose aspirin, have small to moderate benefits when used for prevention of pre-eclampsia.\n                  <\/jats:p>","DOI":"10.1136\/bmj.322.7282.329","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:43:05Z","timestamp":1027752185000},"page":"329-333","source":"Crossref","is-referenced-by-count":186,"title":["Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review"],"prefix":"10.1136","volume":"322","author":[{"given":"Lelia","family":"Duley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Henderson-Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2001,2,10]]},"reference":[{"key":"2025122108191047000_322.7282.329.1","first-page":"1689","article-title":"National high blood pressure education program working group report on high blood pressure in pregnancy","volume":"163","author":"Gifford","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"2025122108191047000_322.7282.329.2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9378(88)90782-X","article-title":"Geographic variation in the incidence of hypertension in pregnancy","volume":"158","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"2025122108191047000_322.7282.329.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1992.tb13818.x"},{"key":"2025122108191047000_322.7282.329.4","unstructured":"Department of Health, Welsh Office, Scottish Home and Health Department, Department of Health and Social Security .Report of confidential enquiries into maternal deaths in the United Kingdom 1994\u20131996. London: HMSO,1998."},{"key":"2025122108191047000_322.7282.329.5","unstructured":"Department of Health .Confidential enquiry into stillbirths and deaths in infancy: 3rd annual report. London: DoH,1996."},{"key":"2025122108191047000_322.7282.329.6","unstructured":"Taylor DJ .The epidemiology of hypertension during pregnancy.In: Rubin PC ed.Hypertension in pregnancy. Amsterdam: Elsevier Science,1988:223\u2013240."},{"key":"2025122108191047000_322.7282.329.7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(80)92746-4","article-title":"Maternal vascular prostacyclin activity in pre-eclampsia","volume":"ii","author":"Bussolino","year":"1980","journal-title":"Lancet"},{"key":"2025122108191047000_322.7282.329.8","unstructured":"Collins R .Antiplatelet agents for IUGR and pre-eclampsia.In: Enkin MW Keirse MJNC Renfrew MJ Neilson JP Crowther C eds.Pregnancy and childbirth module.In: Cochrane Collaboration: Cochrane Pregnancy and Childbirth Database.Issue 2.Oxford: Update Software,1995."},{"key":"2025122108191047000_322.7282.329.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470020086038"},{"key":"2025122108191047000_322.7282.329.10","first-page":"51","article-title":"Efficacite de l'aspirine a faible dose au cours de al grossesse en fonction des facteurs de risque maternels et foetaux","volume":"18","author":"Rey","year":"1996","journal-title":"J S Obstet Gynecol C"},{"key":"2025122108191047000_322.7282.329.11","first-page":"408","article-title":"Low dose aspirin for the prevention of pregnancy-induced hypertension: a meta-analysis","volume":"170","author":"Sanchez-Ramos","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"2025122108191047000_322.7282.329.12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00005721-199205000-00017","article-title":"Aspirin for prevention of pregnancy-induced hypertension","volume":"17","author":"Sharts-Engel","year":"1992","journal-title":"Am J Child Nurs"},{"key":"2025122108191047000_322.7282.329.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb11497.x"},{"key":"2025122108191047000_322.7282.329.14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1471-0528.1996.tb09824.x","article-title":"Where next for prophylaxis against pre-eclampsia?","volume":"103","author":"Broughton Pipkin","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"2025122108191047000_322.7282.329.15","doi-asserted-by":"crossref","unstructured":"Knight M Duley L Henderson-Smart D King J .Antiplatelet agents for preventing and treating pre-eclampsia. In:Cochrane Collaboration: Cochrane Library. Issue 3.Oxford: Update Software,2000.","DOI":"10.1002\/14651858.CD000492"},{"key":"2025122108191047000_322.7282.329.16","unstructured":"Cochrane Controlled Trials Register .In: Cochrane Collaboration:Cochrane Library. Issue 1.In: Oxford: Update Software,1999."},{"key":"2025122108191047000_322.7282.329.17","doi-asserted-by":"crossref","unstructured":"Mulrow CD Oxman AD , eds.Cochrane collaboration handbook. In:Cochrane Collaboration: Cochrane Library. Issue 1.Oxford: Update Software,1999.","DOI":"10.1007\/s101460050011"},{"key":"2025122108191047000_322.7282.329.18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0140-6736(93)92988-6","article-title":"Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"2025122108191047000_322.7282.329.19","first-page":"861","article-title":"Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy","volume":"102","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"2025122108191047000_322.7282.329.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6982.752"},{"key":"2025122108191047000_322.7282.329.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2025122108191047000_322.7282.329.22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1471-0528.1996.tb09823.x","article-title":"Multicentre trials in obstetrics and gynaecology. Smaller explanatory trials are required","volume":"103","author":"Grant","year":"1996","journal-title":"Br J Obstet Gynaecol"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.322.7282.329","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.322.7282.329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T16:19:18Z","timestamp":1766333958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.322.7282.329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,10]]},"references-count":22,"journal-issue":{"issue":"7282","published-online":{"date-parts":[[2001,2,10]]},"published-print":{"date-parts":[[2001,2,10]]}},"alternative-id":["10.1136\/bmj.322.7282.329"],"URL":"https:\/\/doi.org\/10.1136\/bmj.322.7282.329","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2,10]]}}}